Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRIS: CEA plus OMT vs OMT in High-Risk Asymptomatic Carotid Stenosis
NCT02841098Completed
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Sep 2019
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in carotid artery stenosis (CAS) (2 arms), sponsored by Centre Hospitalier Sainte-Anne. Primary endpoint: Ipsilateral stroke or procedural stroke or death at 72 months. Started Sep 2019; status: completed.
02
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT02841098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841098.